Corcept Therapeutics (NASDAQ:CORT) reported a significant increase in third-quarter revenue and raised its full-year guidance, signaling strong growth and a...
Read moreCareTrust REIT, Inc. (NYSE:CTRE) has delivered a robust financial performance in the third quarter of 2024, as reported in their...
Read morePenumbra, Inc. (NYSE: NYSE:PEN), a global healthcare company, reported a significant increase in its third-quarter 2024 revenue, driven by strong...
Read moreAllegiant Travel Company (NASDAQ: NASDAQ:ALGT) held its Q3 2024 earnings call, where CEO Greg Anderson reported a positive airline operating...
Read moreAmarin Corporation (NASDAQ:AMRN), a biopharmaceutical company, has reported a decline in its third-quarter revenue for the year 2024, primarily due...
Read moreRimini Street , Inc. (NASDAQ:RMNI), a global provider of enterprise software products and services, reported mixed financial results for the...
Read moreIn the Q3 2024 Earnings Conference Call held on October 25, 2023, JAKKS Pacific, Inc. (NASDAQ: JAKK) showcased a period...
Read moreFormFactor, Inc. (FORM), a leading semiconductor test equipment supplier, reported a record-breaking revenue of $207.9 million for the third quarter...
Read moreIn a recent earnings call for the first quarter of fiscal year 2025, Microsoft Corporation (NASDAQ:MSFT) reported robust financial results,...
Read moreLPL Financial Holdings Inc. (NASDAQ:LPLA) announced a strong financial performance in its Third Quarter 2024 Earnings Conference Call, with CEO...
Read moreDisclaimer: WallStreetJedi.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.